Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SCN11A | SNV | Missense_Mutation | novel | c.892G>A | p.Asp298Asn | p.D298N | Q9UI33 | protein_coding | tolerated(0.34) | benign(0.321) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
SCN11A | SNV | Missense_Mutation | novel | c.365C>T | p.Ala122Val | p.A122V | Q9UI33 | protein_coding | tolerated(0.05) | benign(0.03) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
SCN11A | SNV | Missense_Mutation | novel | c.4787N>C | p.Val1596Ala | p.V1596A | Q9UI33 | protein_coding | deleterious(0) | probably_damaging(0.965) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | novel | c.1622N>C | p.Glu541Ala | p.E541A | Q9UI33 | protein_coding | deleterious(0.01) | benign(0.057) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | novel | c.1234N>A | p.Ala412Thr | p.A412T | Q9UI33 | protein_coding | deleterious(0.02) | possibly_damaging(0.879) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | rs763315846 | c.1889C>T | p.Ala630Val | p.A630V | Q9UI33 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | | c.94G>A | p.Ala32Thr | p.A32T | Q9UI33 | protein_coding | deleterious(0.04) | benign(0.03) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | rs138034948 | c.1109N>A | p.Arg370His | p.R370H | Q9UI33 | protein_coding | deleterious(0.04) | benign(0.062) | TCGA-BG-A0M9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | novel | c.5305N>T | p.Pro1769Ser | p.P1769S | Q9UI33 | protein_coding | tolerated(0.3) | benign(0.003) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | novel | c.3020C>A | p.Pro1007His | p.P1007H | Q9UI33 | protein_coding | deleterious(0.04) | possibly_damaging(0.54) | TCGA-BK-A56F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL3545209 | NKTR-171 | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL918 | PHENACEMIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1200341 | INDECAINIDE HYDROCHLORIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1201754 | RUFINAMIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | | Tolperisone | TOLPERISONE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1201022 | PHENAZOPYRIDINE HYDROCHLORIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1194 | PRILOCAINE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL919 | FOSPHENYTOIN SODIUM | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1200440 | MEPIVACAINE HYDROCHLORIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | | Lidocaine | LIDOCAINE | |